Literature DB >> 25701296

Managing atrial fibrillation.

Clare L Atzema1, Tyler W Barrett2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25701296      PMCID： PMC4519094          DOI： 10.1016/j.annemergmed.2014.12.010

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN： 0196-0644            Impact factor:   5.721


× No keyword cloud information.
  46 in total

1.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Authors:  Manesh R Patel; Kenneth W Mahaffey; Jyotsna Garg; Guohua Pan; Daniel E Singer; Werner Hacke; Günter Breithardt; Jonathan L Halperin; Graeme J Hankey; Jonathan P Piccini; Richard C Becker; Christopher C Nessel; John F Paolini; Scott D Berkowitz; Keith A A Fox; Robert M Califf
Journal:  N Engl J Med       Date:  2011-08-10       Impact factor: 91.245

2.  2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  L Samuel Wann; Anne B Curtis; Kenneth A Ellenbogen; N A Mark Estes; Michael D Ezekowitz; Warren M Jackman; Craig T January; James E Lowe; Richard L Page; David J Slotwiner; William G Stevenson; Cynthia M Tracy; Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; G Neal Kay; Jean-Yves Le Heuzey; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; L Samuel Wann; Alice K Jacobs; Jeffrey L Anderson; Nancy Albert; Mark A Creager; Steven M Ettinger; Robert A Guyton; Jonathan L Halperin; Judith S Hochman; Frederick G Kushner; Erik Magnus Ohman; William G Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2011-02-14       Impact factor: 29.690

3.  2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Valentin Fuster; Lars E Rydén; Davis S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; G Neal Kay; Jean-Yves Le Huezey; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; L Samuel Wann
Journal:  J Am Coll Cardiol       Date:  2011-03-15       Impact factor: 24.094

4.  Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.

Authors:  Allan C Skanes; Jeff S Healey; John A Cairns; Paul Dorian; Anne M Gillis; M Sean McMurtry; L Brent Mitchell; Atul Verma; Stanley Nattel
Journal:  Can J Cardiol       Date:  2012 Mar-Apr       Impact factor: 5.223

Review 5.  The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Authors:  Kaberi Dasgupta; Robert R Quinn; Kelly B Zarnke; Doreen M Rabi; Pietro Ravani; Stella S Daskalopoulou; Simon W Rabkin; Luc Trudeau; Ross D Feldman; Lyne Cloutier; Ally Prebtani; Robert J Herman; Simon L Bacon; Richard E Gilbert; Marcel Ruzicka; Donald W McKay; Tavis S Campbell; Steven Grover; George Honos; Ernesto L Schiffrin; Peter Bolli; Thomas W Wilson; Patrice Lindsay; Michael D Hill; Shelagh B Coutts; Gord Gubitz; Mark Gelfer; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Donna McLean; J Malcolm O Arnold; Gordon W Moe; Jonathan G Howlett; Jean-Martin Boulanger; Pierre Larochelle; Lawrence A Leiter; Charlotte Jones; Richard I Ogilvie; Vincent Woo; Janusz Kaczorowski; Kevin D Burns; Robert J Petrella; Swapnil Hiremath; Alain Milot; James A Stone; Denis Drouin; Kim L Lavoie; Maxime Lamarre-Cliche; Guy Tremblay; Pavel Hamet; George Fodor; S George Carruthers; George B Pylypchuk; Ellen Burgess; Richard Lewanczuk; George K Dresser; S Brian Penner; Robert A Hegele; Philip A McFarlane; Milan Khara; Andrew Pipe; Paul Oh; Peter Selby; Mukul Sharma; Debra J Reid; Sheldon W Tobe; Raj S Padwal; Luc Poirier
Journal:  Can J Cardiol       Date:  2014-02-22       Impact factor: 5.223

6.  Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.

Authors:  Christian T Ruff; Robert P Giugliano; Eugene Braunwald; Elaine B Hoffman; Naveen Deenadayalu; Michael D Ezekowitz; A John Camm; Jeffrey I Weitz; Basil S Lewis; Alexander Parkhomenko; Takeshi Yamashita; Elliott M Antman
Journal:  Lancet       Date:  2013-12-04       Impact factor: 79.321

7.  Apixaban versus warfarin in patients with atrial fibrillation.

Authors:  Christopher B Granger; John H Alexander; John J V McMurray; Renato D Lopes; Elaine M Hylek; Michael Hanna; Hussein R Al-Khalidi; Jack Ansell; Dan Atar; Alvaro Avezum; M Cecilia Bahit; Rafael Diaz; J Donald Easton; Justin A Ezekowitz; Greg Flaker; David Garcia; Margarida Geraldes; Bernard J Gersh; Sergey Golitsyn; Shinya Goto; Antonio G Hermosillo; Stefan H Hohnloser; John Horowitz; Puneet Mohan; Petr Jansky; Basil S Lewis; Jose Luis Lopez-Sendon; Prem Pais; Alexander Parkhomenko; Freek W A Verheugt; Jun Zhu; Lars Wallentin
Journal:  N Engl J Med       Date:  2011-08-27       Impact factor: 91.245

8.  A population-based description of atrial fibrillation in the emergency department, 2002 to 2010.

Authors:  Clare L Atzema; Peter C Austin; Eli Miller; Alice S Chong; Lingsong Yun; Paul Dorian
Journal:  Ann Emerg Med       Date:  2013-06-27       Impact factor: 5.721

9.  Validation of the Risk Estimator Decision Aid for Atrial Fibrillation (RED-AF) for predicting 30-day adverse events in emergency department patients with atrial fibrillation.

Authors:  Tyler W Barrett; Cathy A Jenkins; Wesley H Self
Journal:  Ann Emerg Med       Date:  2014-09-20       Impact factor: 5.721

10.  Usefulness of a low CHADS2 or CHA2DS2-VASc score to predict normal diagnostic testing in emergency department patients with an acute exacerbation of previously diagnosed atrial fibrillation.

Authors:  Tyler W Barrett; Robert L Abraham; Wesley H Self
Journal:  Am J Cardiol       Date:  2014-03-01       Impact factor: 2.778
View more
  3 in total

1.  Association of atrial fibrillation risk alleles and response to acute rate control therapy.

Authors:  Tyler W Barrett; Wesley H Self; Dawood Darbar; Cathy A Jenkins; Brian S Wasserman; Natasha A Kassim; Michael Casner; M Benjamin Shoemaker
Journal:  Am J Emerg Med       Date:  2016-02-10       Impact factor: 2.469

2.  Thromboprophylaxis for Patients with High-risk Atrial Fibrillation and Flutter Discharged from the Emergency Department.

Authors:  David R Vinson; E Margaret Warton; Dustin G Mark; Dustin W Ballard; Mary E Reed; Uli K Chettipally; Nimmie Singh; Sean Z Bouvet; Bory Kea; Patricia C Ramos; David S Glaser; Alan S Go
Journal:  West J Emerg Med       Date:  2018-02-12

3.  The prevalence, management, and thirty-day outcomes of symptomatic atrial fibrillation in a Tanzanian emergency department.

Authors:  Isaac O Oyediran; Sainikitha Prattipati; Francis M Sakita; Godfrey L Kweka; Tumsifu G Tarimo; Timothy Peterson; Zak Loring; Alexander T Limkakeng; Gerald S Bloomfield; Julian T Hertz
Journal:  Afr J Emerg Med       Date:  2021-10-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.